cDNA accession Links to the sequence |
Tissue most 5' clones in red |
Match mRNA |
From bp to bp in mRNA |
From bp to bp in accs. |
Clone encodes complete protein (with AA variation) |
Features | Anomalies detected by AceView |
Accession match over (% length) |
Base differences relative to genome (% identity) |
AA758938 | .f | 1 to 365 | 365 to 1 | R105* | tiling clone, | 368/368 (100 %) | 2 diff (99.5 %id) | ||
AA325552 | brain, cerebellum | .a | 5843 to 6192 | 1 to 353 | 353/358 (98 %) | 5 diff (98.7 %id) | |||
AK024473 | Spleen | .a | 2333 to 6997 | 1 to 4659 | tiling clone, available from FLJ, | 4659/4659 (100 %) | 19 diff (99.6 %id) | ||
AK074072 | Spleen | .a | 222 to 5722 | 1 to 5496 | tiling clone, available from FLJ, | 5496/5496 (100 %) | 28 diff (99.5 %id) | ||
AL137333 | testis | .a | 5375 to 7003 | 1 to 1629 | tiling clone, available from DKFZ, | 1629/1637 (99 %) | 5 diff (99.7 %id) | ||
AW372797 | breast | .a | 5494 to 5991 | 500 to 2 | 499/503 (99 %) | 0 diff (100 %id) | |||
AW385304 | leiomios | .j-u | 1 to 637 | 661 to 20 | C5Y V22D S23Q Y24I R25S ... | tiling clone, | 642/661 (97 %) | 16 diff (97.6 %id) | |
AW386152 | pnet | .a | 5197 to 5433 | 238 to 2 | 237/238 (99 %) | 0 diff (100 %id) | |||
AW840553 | leiomios | .a | 5781 to 6072 | 296 to 1 | 296/296 (100 %) | 6 diff (98.0 %id) | |||
AW952366 | .a | 5844 to 6497 | 1 to 654 | 654/654 (100 %) | 7 diff (99.0 %id) | ||||
AW970562 | .b | 968 to 1420 | 111 to 563 | 453/563 (80 %) | 6 diff (99.0 %id) | ||||
BE080343 | breast | .a | 5624 to 5835 | 17 to 227 | 211/239 (88 %) | 2 diff (99.2 %id) | |||
BE716316 | head_neck | .a | 5938 to 6113 | 1 to 175 | 175/217 (80 %) | 5 diff (97.7 %id) | |||
BE935195 | marrow | .a | 740 to 877 | 1 to 138 | 138/138 (100 %) | 2 diff (98.6 %id) | |||
BF326026 | amnion_normal | .a | 5894 to 6174 | 280 to 2 | 279/280 (99 %) | 0 diff (100 %id) | |||
BF902431 | marrow | .a | 3030 to 3439 | 433 to 14 | Submitted on the opposite strand | 420/433 (96 %) | 0 diff (100 %id) | ||
BG984989 | colon_normal | .a | 3402 to 3737 | 338 to 1 | 338/338 (100 %) | 6 diff (98.3 %id) | |||
BI018935 | marrow | .a | 2828 to 3278 | 28 to 478 | 451/478 (94 %) | 6 diff (98.8 %id) | |||
BQ336783 | marrow | .a | 1261 to 1517 | 23 to 281 | 259/284 (91 %) | 13 diff (95.5 %id) | |||
BQ352198 | head_neck | .a | 3677 to 3811 | 1 to 134 | 134/140 (95 %) | 10 diff (92.9 %id) | |||
DA112379 | cerebellum | .a | 3030 to 3566 | 2 to 540 | capped | 539/539 (100 %) | 7 diff (98.8 %id) | ||
DA121437 | cerebellum | .a | 2996 to 3529 | 2 to 538 | capped | 537/537 (100 %) | 7 diff (98.7 %id) | ||
DA129320 | alzheimer cortex | .a | 5096 to 5656 | 2 to 562 | capped | 561/561 (100 %) | 0 diff (100 %id) | ||
DA214438 | brain | .a | 3057 to 3616 | 2 to 561 | capped | 560/560 (100 %) | 0 diff (100 %id) | ||
DA278873 | corpus callosum | .a | 4532 to 5080 | 2 to 551 | capped | 550/550 (100 %) | 3 diff (99.5 %id) | ||
DA314133 | hippocampus | .a | 3319 to 3885 | 2 to 568 | capped | 567/567 (100 %) | 0 diff (100 %id) | ||
DA328150 | hippocampus | .a | 3083 to 3717 | 2 to 639 | capped | 638/638 (100 %) | 4 diff (99.4 %id) | ||
DA354565 | substantia nigra | .a | 4445 to 5028 | 2 to 586 | tiling clone, capped | 585/585 (100 %) | 1 diff (99.9 %id) | ||
BX091400 | heart | .a | 6035 to 6743 | 1 to 709 | 709/709 (100 %) | 5 diff (99.3 %id) | |||
BX098856 | .i | 1 to 439 | 1 to 439 | exact | tiling clone, | 439/439 (100 %) | 0 diff (100 %id) | ||
BX113473 | liver and spleen | .b | 920 to 1492 | 1 to 573 | tiling clone, | 573/573 (100 %) | 0 diff (100 %id) | ||
BX281575 | pooled brain, lung, testis | .a | 435 to 967 | 1 to 533 | 533/533 (100 %) | 0 diff (100 %id) | |||
BF727441 | eye, lens | .a | 5504 to 5878 | 407 to 33 | AAA | Possibly primed on the genome, locally A rich (20/22 A in genome downstream of last aligned base) | 375/375 (100 %) | 4 diff (99.0 %id) | |
F05914 | brain, total brain | .a | 4090 to 4397 | 1 to 308 | 308/308 (100 %) | 0 diff (100 %id) | |||
Z38830 | brain, total brain | .a | 5550 to 5848 | 300 to 1 | 300/300 (100 %) | 2 diff (99.4 %id) | |||
Z39665 | brain, total brain | .a | 5368 to 5722 | 355 to 1 | 355/355 (100 %) | 1 diff (99.8 %id) | |||
Z43602 | brain, total brain | .a | 4009 to 4360 | 1 to 352 | 352/352 (100 %) | 8 diff (97.8 %id) | |||
Z39912 | brain, total brain | .a | 6708 to 7001 | 294 to 1 | 294/294 (100 %) | 0 diff (100 %id) | |||
Z43846 | brain, total brain | .a | 5038 to 5307 | 1 to 270 | 270/270 (100 %) | 4 diff (98.6 %id) | |||
F10275 | brain, total brain | .a | 6693 to 7001 | 309 to 1 | 309/309 (100 %) | 2 diff (99.4 %id) | |||
F12662 | brain, total brain | .a | 5086 to 5375 | 1 to 290 | 290/290 (100 %) | 5 diff (98.3 %id) | |||
CD686668 | normal nasopharynx | .a | 4142 to 4754 | 21 to 633 | 613/633 (96 %) | 6 diff (99.1 %id) | |||
CN361506 | embryonic stem cells, cell lines H1, H7, andH9 | .a | 3931 to 4681 | 1 to 752 | tiling clone, | 752/753 (99 %) | 4 diff (99.5 %id) | ||
CR618523 | Placenta Cot 25-normalized | .a | 5836 to 6948 | 1 to 1113 | 1113/1113 (100 %) | 0 diff (100 %id) | |||
AL547488 | placenta, Placenta Cot 25-normalized | .a | 5836 to 6965 | 1 to 1113 | 1113/1116 (99 %) | 26 diff (97.7 %id) | |||
DA437095 | tongue, tumor tissue | .a | 3498 to 4079 | 11 to 595 | capped | 585/594 (98 %) | 6 diff (99.0 %id) | ||
AL044019 | testis | .a | 6363 to 6997 | 663 to 29 | AAA | Possibly primed on the genome, locally A rich (20/22 A in genome downstream of last aligned base) | 635/635 (100 %) | 4 diff (99.4 %id) | |
EL946929 | eyeball | .a | 6544 to 6765 | 1 to 222 | 222/222 (100 %) | 3 diff (98.7 %id) | |||
DA497616 | brain | .a | 4413 to 4976 | 2 to 566 | capped | 565/565 (100 %) | 2 diff (99.7 %id) | ||
CD672759 | eye, Iris | .a | 4793 to 5301 | 1 to 510 | 510/510 (100 %) | 6 diff (98.9 %id) | |||
FN061425 | breast carcinoma | .a | 6058 to 6147 | 1 to 90 | 90/90 (100 %) | 3 diff (96.7 %id) | |||
FN063714 | breast carcinoma | .a | 6327 to 6430 | 105 to 1 | Submitted on the opposite strand | 105/105 (100 %) | 1 diff (99.1 %id) | ||
FN150431 | breast carcinoma | .e-u | 185 to 295 | 108 to 1 | Submitted on the opposite strand | 108/108 (100 %) | 5 diff (95.4 %id) | ||
CD673868. matches multiple genes | eye, lens | .a | 6588 to 7001 | 430 to 17 | AAA | Possibly primed on the genome, locally A rich (20/22 A in genome downstream of last aligned base), also hits gene derloybu | 414/598 (69 %) | 0 diff (100 %id) | |
CD675555 | eye, lens | .a | 3071 to 3686 | 11 to 631 | 621/631 (98 %) | 6 diff (99.1 %id) | |||
DA545259 | .a | 4533 to 5058 | 2 to 528 | capped | 527/527 (100 %) | 2 diff (99.7 %id) | |||
BQ637399 | eye, retina | .a | 6266 to 6864 | 1 to 599 | 599/599 (100 %) | 4 diff (99.4 %id) | |||
T06171 | .a | 6099 to 6434 | 1 to 337 | 337/337 (100 %) | 1 diff (99.8 %id) | ||||
T03709 | .a | 5425 to 5848 | 424 to 1 | 424/424 (100 %) | 1 diff (99.8 %id) | ||||
DR979534 | placenta | .a | 6691 to 6913 | 1 to 222 | Submitted on the opposite strand | 222/227 (97 %) | 8 diff (96.5 %id) | ||
T80028 | whole brain | .a | 5823 to 6239 | 1 to 430 | 430/430 (100 %) | 18 diff (95.9 %id) | |||
R18391 | whole brain | .a | 5738 to 6110 | 1 to 384 | 384/384 (100 %) | 14 diff (96.4 %id) | |||
R50966. matches multiple genes | whole brain | .a | 6632 to 7001 | 393 to 13 | AAA | Possibly primed on the genome, locally A rich (20/22 A in genome downstream of last aligned base), also hits gene zeysku | 381/437 (87 %) | 21 diff (95.2 %id) | |
R52749 | whole brain | .a | 5738 to 6104 | 1 to 376 | 376/419 (89 %) | 17 diff (96.0 %id) | |||
H15452 | whole brain | .a | 5154 to 5722 | 588 to 13 | AAA | Possibly primed on the genome, locally A rich (20/22 A in genome downstream of last aligned base) | 576/576 (100 %) | 28 diff (95.2 %id) | |
H15511 | whole brain | .a | 4011 to 4415 | 1 to 405 | Possibly primed on the genome, locally A rich (20/22 A in genome downstream of last aligned base) | 405/405 (100 %) | 3 diff (99.3 %id) | ||
H15272 | whole brain | .a | 4011 to 4467 | 1 to 462 | 462/464 (99 %) | 13 diff (97.2 %id) | |||
H15273 | whole brain | .a | 5143 to 5723 | 594 to 9 | 586/613 (95 %) | 0 diff (100 %id) | |||
H17138 | whole brain | .a | 6548 to 7001 | 480 to 10 | 471/490 (96 %) | 0 diff (100 %id) | |||
T83082 | liver and spleen | .b | 921 to 1258 | 1 to 343 | 343/398 (86 %) | 15 diff (96.3 %id) | |||
T90546 | liver and spleen | .b | 1260 to 1581 | 323 to 1 | 323/329 (98 %) | 1 diff (99.7 %id) | |||
R50390 | breast | .a | 6677 to 7000 | 341 to 1 | 341/355 (96 %) | 19 diff (94.7 %id) | |||
N51921. matches multiple genes | multiple sclerosis lesions | .a | 6519 to 6997 | 493 to 1 | also hits gene MTM1 | 493/494 (99 %) | 18 diff (96.4 %id) | ||
N53747. matches multiple genes | multiple sclerosis lesions | .a | 5959 to 6143 | 1 to 186 | also hits gene MTM1 | 186/203 (91 %) | 3 diff (98.6 %id) | ||
W94660 | heart | .a | 6552 to 7001 | 460 to 10 | 451/460 (98 %) | 0 diff (100 %id) | |||
W95988 | heart | .a | 6035 to 6515 | 1 to 485 | 485/485 (100 %) | 8 diff (98.4 %id) | |||
AA721993 | pineal gland | .a | 5303 to 5723 | 423 to 3 | 421/423 (99 %) | 0 diff (100 %id) | |||
AA058705 | uterus | .a | 6587 to 6997 | 419 to 1 | 419/422 (99 %) | 10 diff (97.7 %id) | |||
AA708430 | uterus | .a | 6600 to 6997 | 398 to 1 | 398/398 (100 %) | 0 diff (100 %id) | |||
AA132916 | colon, tumor | .a | 1138 to 1511 | 386 to 1 | 384/388 (98 %) | 26 diff (93.3 %id) | |||
AA133004 | colon, tumor | .a | 646 to 1080 | 1 to 436 | 436/452 (96 %) | 7 diff (98.5 %id) | |||
AI732564 | colon, tumor | .a | 983 to 1466 | 483 to 1 | 483/483 (100 %) | 1 diff (99.8 %id) | |||
AI733855 | colon, tumor | .a | 645 to 1214 | 1 to 570 | 570/570 (100 %) | 4 diff (99.3 %id) | |||
AA262200 | germinal center B cell | .a | 5698 to 5983 | 1 to 286 | 286/286 (100 %) | 2 diff (99.4 %id) | |||
AA262201 | germinal center B cell | .a | 6611 to 6998 | 390 to 3 | 388/390 (99 %) | 0 diff (100 %id) | |||
AA397573 | .d | 1 to 298 | 1 to 298 | tiling clone, fully sequenced, | 298/298 (100 %) | 2 diff (99.4 %id) | |||
AA399544 | .d | 268 to 625 | 358 to 1 | tiling clone, fully sequenced, | 358/358 (100 %) | 8 diff (97.8 %id) | |||
AA480854 | germinal center B cell | .a | 6461 to 6997 | 549 to 13 | AAA | Possibly primed on the genome, locally A rich (20/22 A in genome downstream of last aligned base) | 537/537 (100 %) | 2 diff (99.7 %id) | |
AA480910 | germinal center B cell | .a | 5750 to 6142 | 1 to 392 | Possibly primed on the genome, locally A rich (20/22 A in genome downstream of last aligned base) | 392/392 (100 %) | 3 diff (99.3 %id) | ||
AA505067. matches multiple genes | germinal center B cell | .a | 6600 to 7001 | 412 to 11 | AAA | Possibly primed on the genome, locally A rich (20/22 A in genome downstream of last aligned base), also hits gene KDM4A | 402/402 (100 %) | 2 diff (99.6 %id) | |
AA505069. matches multiple genes | germinal center B cell | .a | 6089 to 6520 | 1 to 432 | also hits gene TNFSF10 | 432/432 (100 %) | 6 diff (98.7 %id) | ||
AA501792 | liposarcoma | .b | 1151 to 1381 | 1 to 231 | 231/231 (100 %) | 0 diff (100 %id) | |||
AA651758 | germinal center B cell | .a | 6593 to 7001 | 429 to 20 | 410/429 (95 %) | 0 diff (100 %id) | |||
AA747662 | germinal center B cell | .a | 6601 to 7001 | 403 to 2 | 402/403 (99 %) | 0 diff (100 %id) | |||
AA766698 | germinal center B cell | .a | 6545 to 7001 | 466 to 10 | 457/466 (98 %) | 0 diff (100 %id) | |||
AA741198 | 2 pooled tumors (clear cell type), Kidney | .a | 6490 to 6913 | 427 to 4 | 424/427 (99 %) | 0 diff (100 %id) | |||
AA812004 | germinal center B cell | .a | 5328 to 5722 | 425 to 31 | AAA | Possibly primed on the genome, locally A rich (20/22 A in genome downstream of last aligned base) | 395/395 (100 %) | 0 diff (100 %id) | |
AI023107 | parathyroid gland, parathyroid tumor | .a | 6513 to 7001 | 494 to 7 | 488/498 (97 %) | 0 diff (100 %id) | |||
AI023479 | liver and spleen | .a | 6643 to 7001 | 358 to 1 | 358/358 (100 %) | 2 diff (99.5 %id) | |||
AI204661 | heart | .a | 6519 to 6997 | 478 to 1 | 478/480 (99 %) | 3 diff (99.4 %id) | |||
AI203453 | .b | 1183 to 1593 | 408 to 1 | tiling clone, | 408/408 (100 %) | 4 diff (99.1 %id) | |||
AI187832 | .i | 250 to 499 | 250 to 2 | 249/250 (99 %) | 0 diff (100 %id) | ||||
AI365018 | pooled germ cell tumors | .a | 6702 to 7001 | 304 to 5 | 300/304 (98 %) | 0 diff (100 %id) | |||
AI369000 | poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus | .a | 6549 to 6911 | 373 to 11 | AAA | Possibly primed on the genome, locally A rich (20/22 A in genome downstream of last aligned base) | 363/363 (100 %) | 1 diff (99.8 %id) | |
AI420002 | pooled | .a | 1058 to 1511 | 457 to 4 | 454/457 (99 %) | 0 diff (100 %id) | |||
AI431749 | Kidney | .a | 6608 to 7001 | 396 to 3 | 394/396 (99 %) | 0 diff (100 %id) | |||
AI800243 | Kidney | .a | 5453 to 5736 | 287 to 4 | 284/287 (98 %) | 0 diff (100 %id) | |||
AI457305 | carcinoid, lung | .h | 1 to 460 | 10 to 469 | exact | tiling clone, | Submitted on the opposite strand | 460/460 (100 %) | 0 diff (100 %id) |
AI566021 | Kidney | .a | 6662 to 7001 | 340 to 1 | 340/340 (100 %) | 2 diff (99.5 %id) | |||
AI491882 | moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus | .e-u | 169 to 628 | 461 to 1 | tiling clone, | 461/461 (100 %) | 1 diff (99.8 %id) | ||
AI499394 | moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus | .a | 6551 to 7001 | 451 to 1 | 451/451 (100 %) | 1 diff (99.8 %id) | |||
AI587235 | uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors | .a | 5415 to 5723 | 309 to 1 | 309/309 (100 %) | 0 diff (100 %id) | |||
AI587236 | uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors | .a | 5555 to 5722 | 168 to 1 | 168/168 (100 %) | 0 diff (100 %id) | |||
AI583735 | pooled germ cell tumors | .a | 5361 to 5736 | 384 to 9 | 376/384 (97 %) | 0 diff (100 %id) | |||
AI671496 | pooled germ cell tumors | .g | 73 to 536 | 469 to 6 | tiling clone, | 464/469 (98 %) | 0 diff (100 %id) | ||
AI807351 | pooled | .e-u | 1 to 623 | 623 to 1 | Q21X | tiling clone, | 623/623 (100 %) | 2 diff (99.7 %id) | |
AI927322 | Kidney | .a | 5256 to 5723 | 473 to 6 | 468/473 (98 %) | 0 diff (100 %id) | |||
AI962715 | pooled germ cell tumors | .g | 1 to 536 | 541 to 6 | exact | tiling clone, | 536/541 (99 %) | 0 diff (100 %id) | |
BI491504 | cochlea, ear | .a | 6678 to 6884 | 207 to 1 | fully sequenced, | Possibly primed on the genome, locally A rich (20/22 A in genome downstream of last aligned base) | 207/207 (100 %) | 2 diff (99.1 %id) | |
BI491505 | cochlea, ear | .a | 6553 to 6908 | 1 to 356 | fully sequenced, AAA | Possibly primed on the genome, locally A rich (20/22 A in genome downstream of last aligned base) | 356/356 (100 %) | 8 diff (97.8 %id) | |
AW002186 | thymus, pooled | .a | 6704 to 7003 | 301 to 2 | 300/301 (99 %) | 0 diff (100 %id) | |||
AW055272 | serous papillary carcinoma, high grade, 2pooled tumors, uterus | .a | 6515 to 6998 | 487 to 4 | 484/487 (99 %) | 0 diff (100 %id) | |||
AW297615 | .a | 6552 to 7001 | 467 to 18 | AAA | Possibly primed on the genome, locally A rich (20/22 A in genome downstream of last aligned base) | 450/450 (100 %) | 3 diff (99.4 %id) | ||
AW298704 | .a | 6488 to 7001 | 531 to 18 | AAA | Possibly primed on the genome, locally A rich (20/22 A in genome downstream of last aligned base) | 514/514 (100 %) | 1 diff (99.9 %id) | ||
AW262876 | brain, three pooled meningiomas | .a | 6497 to 6997 | 512 to 12 | AAA | Possibly primed on the genome, locally A rich (20/22 A in genome downstream of last aligned base) | 501/501 (100 %) | 2 diff (99.7 %id) | |
AW340380 | pooled | .a | 6436 to 7001 | 569 to 4 | 566/569 (99 %) | 0 diff (100 %id) | |||
AW418740 | pooled | .a | 6474 to 7001 | 531 to 4 | 528/531 (99 %) | 0 diff (100 %id) | |||
AW665172 | pooled | .a | 5297 to 5722 | 426 to 1 | 426/426 (100 %) | 5 diff (98.9 %id) | |||
BE272348 | adenocarcinoma cell line, ovary | .a | 5684 to 6093 | 1 to 417 | 417/419 (99 %) | 14 diff (96.7 %id) | |||
AW779922 | Kidney | .i | 230 to 690 | 461 to 1 | tiling clone, | 461/461 (100 %) | 1 diff (99.8 %id) | ||
BU428462 | lymph | .a | 3592 to 4097 | 1 to 506 | 506/506 (100 %) | 6 diff (98.9 %id) | |||
BU428768 | lymph | .a | 4166 to 4572 | 8 to 414 | 407/414 (98 %) | 6 diff (98.6 %id) | |||
BU431650 | lymph | .a | 3759 to 4354 | 8 to 603 | 596/603 (98 %) | 6 diff (99.1 %id) | |||
AW500882 | lymph | .a | 3434 to 3888 | 8 to 464 | 457/464 (98 %) | 6 diff (98.8 %id) | |||
AW501648 | lymph | .a | 3004 to 3490 | 7 to 493 | 487/493 (98 %) | 6 diff (98.8 %id) | |||
AW502580 | lymph | .a | 574 to 940 | 29 to 395 | 367/405 (90 %) | 9 diff (97.8 %id) | |||
AW504575 | lymph | .a | 3127 to 3565 | 8 to 448 | 441/448 (98 %) | 6 diff (98.7 %id) | |||
AW504902 | lymph | .a | 3646 to 4131 | 1 to 486 | 486/486 (100 %) | 8 diff (98.4 %id) | |||
CF138148 | lymph | .a | 3796 to 4253 | 1 to 458 | 458/458 (100 %) | 7 diff (98.5 %id) | |||
CF147432 | lymph | .a | 574 to 913 | 22 to 360 | 339/360 (94 %) | 7 diff (98.1 %id) | |||
CF142980 | lymph | .a | 3067 to 3522 | 1 to 455 | 455/455 (100 %) | 7 diff (98.5 %id) | |||
CF143224 | lymph | .a | 577 to 807 | 32 to 261 | 230/278 (82 %) | 12 diff (95.7 %id) | |||
CF143885 | lymph | .a | 3434 to 3802 | 8 to 378 | 371/378 (98 %) | 6 diff (98.5 %id) | |||
BE501940 | Kidney | .a | 6729 to 7001 | 279 to 7 | 273/279 (97 %) | 0 diff (100 %id) | |||
BE268148 | Burkitt lymphoma, lymph | .a | 4518 to 5147 | 1 to 623 | 623/731 (85 %) | 11 diff (98.5 %id) | |||
BF109646 | pooled | .a | 5324 to 5723 | 406 to 9 | 398/406 (98 %) | 0 diff (100 %id) | |||
BE397763 | Burkitt lymphoma, lymph | .a | 4493 to 5104 | 31 to 643 | 613/644 (95 %) | 10 diff (98.5 %id) | |||
BE513881 | Burkitt lymphoma, lymph | .a | 4518 to 5190 | 1 to 671 | 671/677 (99 %) | 11 diff (98.4 %id) | |||
BC013346 | Lymph, Burkitt lymphoma | .a | 4499 to 7001 | 1 to 2504 | tiling clone, available from MGC, AAA | Possibly primed on the genome, locally A rich (20/22 A in genome downstream of last aligned base) | 2504/2504 (100 %) | 8 diff (99.7 %id) | |
BE561342 | Burkitt lymphoma, lymph | .a | 4518 to 5126 | 1 to 607 | available from MGC, | 607/607 (100 %) | 2 diff (99.7 %id) | ||
BE742775 | adenocarcinoma cell line, ovary | .a | 5688 to 6544 | 1 to 844 | 844/854 (98 %) | 28 diff (96.8 %id) | |||
BE785099 | large cell carcinoma, lung | .a | 5205 to 5698 | 1 to 498 | 498/588 (84 %) | 11 diff (98.2 %id) | |||
BG429735 | Kidney | .a | 5738 to 6492 | 1 to 770 | 770/770 (100 %) | 22 diff (97.2 %id) | |||
BG685367 | B-cells, primary B-cells from tonsils (cell line) | .a | 4942 to 5683 | 1 to 746 | tiling clone, | 746/915 (81 %) | 22 diff (97.6 %id) | ||
BG742755 | skin | .a | 5800 to 6717 | 1 to 920 | 920/922 (99 %) | 17 diff (98.2 %id) | |||
BG758345 | B-cells, primary B-cells from tonsils (cell line) | .a | 4942 to 5954 | 1 to 1005 | 1005/1006 (99 %) | 48 diff (95.3 %id) | |||
BG757101 | B-cells, primary B-cells from tonsils (cell line) | .a | 4158 to 4780 | 1 to 631 | 631/773 (81 %) | 18 diff (97.7 %id) | |||
BI225193 | Burkitt lymphoma, lymph | .a | 4498 to 5017 | 1 to 534 | 534/588 (90 %) | 42 diff (92.9 %id) | |||
BC029857 | Brain, Lung, Testis, adult, pooled whole | .b | 1 to 1626 | 1 to 1626 | exact | tiling clone, available from MGC, AAA | Possibly primed on the genome, locally A rich (20/22 A in genome downstream of last aligned base) | 1626/1626 (100 %) | 3 diff (99.9 %id) |
BI821590 | pooled brain, lung, testis | .a | 435 to 1034 | 1 to 599 | available from MGC, | 599/604 (99 %) | 4 diff (99.4 %id) | ||
BM051844 | Burkitt lymphoma, lymph | .a | 4498 to 5190 | 1 to 693 | 693/693 (100 %) | 13 diff (98.2 %id) | |||
BM452531 | lymph, lymphoma, cell line | .a | 5817 to 6694 | 1 to 883 | 883/1010 (87 %) | 8 diff (99.3 %id) | |||
BM894266 | insulinoma, Pancreas | .a | 6483 to 6911 | 450 to 22 | AAA | Possibly primed on the genome, locally A rich (20/22 A in genome downstream of last aligned base) | 429/429 (100 %) | 1 diff (99.8 %id) | |
CK824118 | insulinoma, Pancreas | .a | 6393 to 6907 | 515 to 1 | 515/515 (100 %) | 2 diff (99.7 %id) | |||
BM907526 | large cell carcinoma, lung | .a | 6125 to 7001 | 923 to 22 | Submitted on the opposite strand | 902/1063 (84 %) | 0 diff (100 %id) | ||
BQ017031 | lung, Metastatic Chondrosarcoma | .a | 6731 to 6908 | 197 to 19 | AAA | Possibly primed on the genome, locally A rich (20/22 A in genome downstream of last aligned base) | 179/179 (100 %) | 1 diff (99.5 %id) | |
BQ017316 | lung, Metastatic Chondrosarcoma | .a | 5198 to 5722 | 540 to 15 | AAA | Possibly primed on the genome, locally A rich (20/22 A in genome downstream of last aligned base) | 526/526 (100 %) | 1 diff (99.9 %id) | |
BQ218823 | embryonal carcinoma, cell line, testis | .a | 3863 to 4681 | 1 to 829 | 829/896 (92 %) | 14 diff (98.5 %id) | |||
BU168746 | ductal carcinoma, cell line, Pancreas | .a | 5966 to 6779 | 1 to 822 | 822/913 (90 %) | 25 diff (97.3 %id) | |||
BU156649 | leiomyosarcoma, uterus | .a | 5868 to 6746 | 1 to 883 | 883/884 (99 %) | 9 diff (99.0 %id) | |||
BQ691070 | ductal carcinoma, cell line, Pancreas | .a | 5966 to 6855 | 1 to 895 | 895/895 (100 %) | 9 diff (99.0 %id) | |||
BQ945749 | epidermoid carcinoma, cell line, lung | .a | 3240 to 4042 | 1 to 817 | 817/960 (85 %) | 19 diff (98.1 %id) | |||
BU527696 | epidermoid carcinoma, cell line, lung | .a | 4979 to 5867 | 37 to 927 | 891/927 (96 %) | 6 diff (99.4 %id) | |||
CF121709 | lymph | .a | 3434 to 4146 | 8 to 720 | 713/720 (99 %) | 6 diff (99.2 %id) | |||
CF121750 | lymph | .a | 3067 to 3774 | 1 to 708 | 708/708 (100 %) | 5 diff (99.3 %id) | |||
CF144040 | lymph | .a | 3434 to 3920 | 8 to 496 | 489/496 (98 %) | 6 diff (98.8 %id) | |||
CF786068 | mixed | .a | 3154 to 3868 | 32 to 744 | 713/820 (86 %) | 26 diff (96.9 %id) | |||
TI_57199281 | .a | 435 to 1034 | 70 to 668 | 599/673 (89 %) | 10 diff (98.6 %id) | ||||
DA643358 | .a | 4874 to 5413 | 2 to 542 | capped | 541/541 (100 %) | 6 diff (98.9 %id) | |||
NM_001080530.2 | .a | 1 to 7008 | 1 to 7008 | exact | RefSeq, | 7008/7011 (99 %) | 5 diff (100.0 %id) | ||
DA681284 | ovary | .a | 3438 to 3993 | 2 to 559 | capped | 558/558 (100 %) | 4 diff (99.3 %id) | ||
DA732645 | .a | 3760 to 4350 | 2 to 592 | capped | 591/592 (99 %) | 4 diff (99.4 %id) | |||
DB364221 | .a | 6516 to 7002 | 491 to 1 | 491/491 (100 %) | 16 diff (96.8 %id) | ||||
DA770571 | brain | .a | 4333 to 4898 | 2 to 567 | capped | 566/566 (100 %) | 1 diff (99.9 %id) | ||
DA786274 | brain | .a | 3757 to 4344 | 2 to 589 | capped | 588/588 (100 %) | 10 diff (98.3 %id) | ||
DA808549 | brain | .a | 3440 to 4022 | 2 to 589 | capped | 588/588 (100 %) | 4 diff (99.4 %id) | ||
DA833156 | placenta | .a | 4946 to 5693 | 2 to 758 | capped | 757/757 (100 %) | 21 diff (97.3 %id) | ||
DB379750 | placenta | .a | 6468 to 7002 | 532 to 1 | 532/534 (99 %) | 25 diff (95.4 %id) | |||
DA839938 | placenta | .a | 4337 to 4894 | 2 to 559 | capped | 558/559 (99 %) | 2 diff (99.7 %id) | ||
DA949094 | Spleen | .a | 4545 to 5086 | 2 to 544 | capped | 543/543 (100 %) | 3 diff (99.5 %id) | ||
BM145523 | leukopheresis | .a | 2764 to 3151 | 1 to 388 | tiling clone, | 388/388 (100 %) | 20 diff (94.9 %id) | ||
BE244098 | leukopheresis | .a | 5539 to 5922 | 382 to 1 | 382/382 (100 %) | 5 diff (98.7 %id) | |||
BE246183 | leukopheresis | .a | 5560 to 5922 | 362 to 1 | 362/362 (100 %) | 5 diff (98.7 %id) | |||
BE245441 | leukopheresis | .a | 2764 to 3067 | 1 to 305 | 305/305 (100 %) | 9 diff (97.1 %id) | |||
BE245554 | leukopheresis | .a | 5493 to 5922 | 431 to 1 | 431/431 (100 %) | 14 diff (96.8 %id) | |||
BE247744 | leukopheresis | .a | 2764 to 3235 | 1 to 471 | 471/471 (100 %) | 7 diff (98.6 %id) | |||
DB048808 | testis | .a | 3269 to 3833 | 2 to 571 | capped | 570/570 (100 %) | 6 diff (99.0 %id) | ||
DB143594 | thymus | .a | 2540 to 3102 | 2 to 564 | capped | 563/564 (99 %) | 4 diff (99.3 %id) | ||
DB156186 | thymus | .a | 3747 to 4300 | 2 to 555 | capped | 554/554 (100 %) | 1 diff (99.9 %id) | ||
DB163707 | thymus | .a | 4195 to 4783 | 2 to 590 | capped | 589/589 (100 %) | 1 diff (99.9 %id) | ||
TI_149311624 | .a | 6241 to 7002 | 834 to 81 | AAA | Possibly primed on the genome, locally A rich (20/22 A in genome downstream of last aligned base) | 754/925 (81 %) | 13 diff (98.6 %id) | ||
TI_154072341 | .a | 6467 to 7001 | 593 to 66 | 528/987 (53 %) | 0 diff (100 %id) | ||||
TI_154087938 | .e-u | 143 to 654 | 580 to 67 | tiling clone, | 514/679 (75 %) | 0 diff (100 %id) | |||
TI_154149265 | .a | 3599 to 4294 | 80 to 773 | 694/835 (83 %) | 19 diff (97.8 %id) | ||||
TI_154149645 | .a | 4166 to 4688 | 77 to 599 | 523/524 (99 %) | 1 diff (99.9 %id) | ||||
TI_154153639 | .a | 3759 to 4374 | 80 to 695 | 616/616 (100 %) | 2 diff (99.7 %id) | ||||
TI_154155296 | .a | 3434 to 3939 | 80 to 587 | 508/508 (100 %) | 8 diff (98.5 %id) | ||||
TI_154156721 | .a | 3004 to 3513 | 79 to 588 | 510/510 (100 %) | 2 diff (99.7 %id) | ||||
TI_154158095 | .a | 574 to 940 | 106 to 472 | 367/542 (67 %) | 10 diff (98.2 %id) | ||||
TI_154160791 | .a | 3127 to 3687 | 84 to 646 | 563/565 (99 %) | 13 diff (97.7 %id) | ||||
TI_154161310 | .a | 3652 to 4220 | 66 to 634 | 569/569 (100 %) | 9 diff (98.5 %id) | ||||
TI_154167914 | .a | 3803 to 4409 | 96 to 704 | 609/933 (65 %) | 16 diff (98.3 %id) | ||||
TI_154174212 | .a | 3074 to 3702 | 87 to 716 | 630/634 (99 %) | 17 diff (97.4 %id) | ||||
TI_154175604 | .a | 3434 to 3846 | 80 to 494 | 415/416 (99 %) | 6 diff (98.6 %id) | ||||
TI_154175895 | .a | 3434 to 3941 | 90 to 601 | 512/950 (53 %) | 13 diff (98.7 %id) | ||||
TI_154180713 | .a | 3004 to 3824 | 75 to 893 | 819/893 (91 %) | 6 diff (99.4 %id) | ||||
TI_154180950 | .a | 3434 to 4243 | 76 to 877 | 802/804 (99 %) | 22 diff (97.3 %id) | ||||
TI_154181024 | .a | 3074 to 3875 | 69 to 867 | tiling clone, | 799/800 (99 %) | 10 diff (98.8 %id) | |||
TI_154185344 | .a | 574 to 940 | 105 to 470 | 366/1412 (25 %) | 10 diff (99.3 %id) | ||||
TI_157605958 | .b | 1007 to 1590 | 685 to 99 | AAA | Possibly primed on the genome, locally A rich (20/22 A in genome downstream of last aligned base) | 587/951 (61 %) | 16 diff (98.4 %id) | ||
TI_157607860 | .a | 6448 to 6997 | 637 to 88 | AAA | Possibly primed on the genome, locally A rich (20/22 A in genome downstream of last aligned base) | 550/551 (99 %) | 12 diff (97.9 %id) | ||
BQ011567 | placenta | .a | 6538 to 6997 | 478 to 19 | AAA | Possibly primed on the genome, locally A rich (20/22 A in genome downstream of last aligned base) | 460/460 (100 %) | 2 diff (99.6 %id) | |
CF529768 | placenta | .a | 6635 to 6997 | 381 to 19 | AAA | Possibly primed on the genome, locally A rich (20/22 A in genome downstream of last aligned base) | 363/363 (100 %) | 0 diff (100 %id) | |
BM977424 | lung, Primary Lung Cystic Fibrosis EpithelialCells | .a | 6291 to 7002 | 727 to 19 | AAA | Possibly primed on the genome, locally A rich (20/22 A in genome downstream of last aligned base) | 709/710 (99 %) | 7 diff (99.1 %id) | |
BM668241 | eye, Retina Foveal and Macular | .c | 273 to 682 | 429 to 19 | tiling clone, fully sequenced, AAA | 411/411 (100 %) | 1 diff (99.8 %id) | ||
BM692924 | eye, Retina Foveal and Macular | .c | 1 to 334 | 1 to 334 | tiling clone, fully sequenced, | 334/334 (100 %) | 1 diff (99.8 %id) | ||
BM668748 | eye, Retina Foveal and Macular | .a | 6426 to 6997 | 590 to 19 | fully sequenced, AAA | Possibly primed on the genome, locally A rich (20/22 A in genome downstream of last aligned base) | 572/572 (100 %) | 2 diff (99.7 %id) | |
BM693470 | eye, Retina Foveal and Macular | .a | 6059 to 6456 | 1 to 398 | fully sequenced, | Possibly primed on the genome, locally A rich (20/22 A in genome downstream of last aligned base) | 398/398 (100 %) | 2 diff (99.5 %id) | |
BM688011 | eye, human retina | .a | 6087 to 6681 | 8 to 599 | fully sequenced, | Possibly primed on the genome, locally A rich (20/22 A in genome downstream of last aligned base) | 592/599 (98 %) | 2 diff (99.7 %id) | |
BU726874 | eye, human retina | .a | 6651 to 6998 | 366 to 19 | fully sequenced, AAA | Possibly primed on the genome, locally A rich (20/22 A in genome downstream of last aligned base) | 348/348 (100 %) | 2 diff (99.5 %id) | |
BM692032 | eye, human retina | .a | 6272 to 6831 | 9 to 568 | 560/568 (98 %) | 1 diff (99.9 %id) | |||
BM713793 | eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid | .a | 6432 to 7001 | 1 to 570 | 570/576 (98 %) | 4 diff (99.4 %id) | |||
BM682281 | eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid | .a | 5112 to 5722 | 625 to 15 | AAA | Possibly primed on the genome, locally A rich (20/22 A in genome downstream of last aligned base) | 611/611 (100 %) | 7 diff (98.9 %id) | |
BM723275 | eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid | .a | 4354 to 5101 | 1 to 745 | Possibly primed on the genome, locally A rich (20/22 A in genome downstream of last aligned base) | 745/746 (99 %) | 8 diff (99.0 %id) | ||
BQ185983 | eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid | .a | 5040 to 5524 | 1 to 486 | 486/486 (100 %) | 9 diff (98.2 %id) | |||
BQ187309 | eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid | .a | 5036 to 5726 | 1 to 691 | AAA | Possibly primed on the genome, locally A rich (20/22 A in genome downstream of last aligned base) | 691/691 (100 %) | 1 diff (99.9 %id) | |
CA442391 | Fibrosarcoma | .a | 6143 to 6911 | 784 to 16 | AAA | Possibly primed on the genome, locally A rich (20/22 A in genome downstream of last aligned base) | 769/769 (100 %) | 2 diff (99.8 %id) | |
BQ445922 | Knee, Osteoarthritic Cartilage | .a | 6292 to 6997 | 723 to 19 | AAA | Possibly primed on the genome, locally A rich (20/22 A in genome downstream of last aligned base) | 705/705 (100 %) | 3 diff (99.6 %id) | |
TI_151707269 | .a | 6212 to 6998 | 877 to 88 | 790/1418 (55 %) | 0 diff (100 %id) | ||||
TI_151734285 | .a | 5035 to 5726 | 773 to 83 | tiling clone, AAA | Possibly primed on the genome, locally A rich (20/22 A in genome downstream of last aligned base) | 691/933 (74 %) | 0 diff (100 %id) | ||
DB268389 | uterus | .a | 4919 to 5473 | 2 to 557 | capped | 556/556 (100 %) | 6 diff (99.0 %id) | ||
W22321 | eye, retina | .a | 2641 to 3086 | 451 to 10 | 442/506 (87 %) | 0 diff (100 %id) | |||
BX648908 | human cerebellum | .a | 6468 to 7002 | 532 to 1 | available from DKFZ, AAA | Suspected internal deletion, this clone was ignored | 532/534 (99 %) | 25 diff (95.4 %id) | |
AW291496 | .a | 4337 to 4894 | 2 to 559 | AAA | This clone was ignored | 558/559 (99 %) | 2 diff (99.7 %id) | ||
DA949094 | Spleen | .a | 4545 to 5086 | 2 to 544 | capped | 543/543 (100 %) | 3 diff (99.5 %id) | ||
BM145523 | leukopheresis | .a | 2764 to 3151 | 1 to 388 | tiling clone, | 388/388 (100 %) | 20 diff (94.9 %id) | ||
BE244098 | leukopheresis | .a | 5539 to 5922 | 382 to 1 | 382/382 (100 %) | 5 diff (98.7 %id) | |||
BE246183 | leukopheresis | .a | 5560 to 5922 | 362 to 1 | 362/362 (100 %) | 5 diff (98.7 %id) | |||
BE245441 | leukopheresis | .a | 2764 to 3067 | 1 to 305 | 305/305 (100 %) | 9 diff (97.1 %id) | |||
BE245554 | leukopheresis | .a | 5493 to 5922 | 431 to 1 | 431/431 (100 %) | 14 diff (96.8 %id) | |||
BE247744 | leukopheresis | .a | 2764 to 3235 | 1 to 471 | 471/471 (100 %) | 7 diff (98.6 %id) | |||
DB048808 | testis | .a | 3269 to 3833 | 2 to 571 | capped | 570/570 (100 %) | 6 diff (99.0 %id) | ||
DB143594 | thymus | .a | 2540 to 3102 | 2 to 564 | capped | 563/564 (99 %) | 4 diff (99.3 %id) | ||
DB156186 | thymus | .a | 3747 to 4300 | 2 to 555 | capped | 554/554 (100 %) | 1 diff (99.9 %id) | ||
DB163707 | thymus | .a | 4195 to 4783 | 2 to 590 | capped | 589/589 (100 %) | 1 diff (99.9 %id) | ||
TI_149311624 | .a | 6241 to 7002 | 834 to 81 | AAA | Possibly primed on the genome, locally A rich (20/22 A in genome downstream of last aligned base) | 754/925 (81 %) | 13 diff (98.6 %id) | ||
TI_154072341 | .a | 6467 to 7001 | 593 to 66 | 528/987 (53 %) | 0 diff (100 %id) | ||||
TI_154087938 | .e-u | 143 to 654 | 580 to 67 | tiling clone, | 514/679 (75 %) | 0 diff (100 %id) | |||
TI_154149265 | .a | 3599 to 4294 | 80 to 773 | 694/835 (83 %) | 19 diff (97.8 %id) | ||||
TI_154149645 | .a | 4166 to 4688 | 77 to 599 | 523/524 (99 %) | 1 diff (99.9 %id) | ||||
TI_154153639 | .a | 3759 to 4374 | 80 to 695 | 616/616 (100 %) | 2 diff (99.7 %id) | ||||
TI_154155296 | .a | 3434 to 3939 | 80 to 587 | 508/508 (100 %) | 8 diff (98.5 %id) | ||||
TI_154156721 | .a | 3004 to 3513 | 79 to 588 | 510/510 (100 %) | 2 diff (99.7 %id) | ||||
TI_154158095 | .a | 574 to 940 | 106 to 472 | 367/542 (67 %) | 10 diff (98.2 %id) | ||||
TI_154160791 | .a | 3127 to 3687 | 84 to 646 | 563/565 (99 %) | 13 diff (97.7 %id) | ||||
TI_154161310 | .a | 3652 to 4220 | 66 to 634 | 569/569 (100 %) | 9 diff (98.5 %id) | ||||
TI_154167914 | .a | 3803 to 4409 | 96 to 704 | 609/933 (65 %) | 16 diff (98.3 %id) | ||||
TI_154174212 | .a | 3074 to 3702 | 87 to 716 | 630/634 (99 %) | 17 diff (97.4 %id) | ||||
TI_154175604 | .a | 3434 to 3846 | 80 to 494 | 415/416 (99 %) | 6 diff (98.6 %id) | ||||
TI_154175895 | .a | 3434 to 3941 | 90 to 601 | 512/950 (53 %) | 13 diff (98.7 %id) | ||||
TI_154180713 | .a | 3004 to 3824 | 75 to 893 | 819/893 (91 %) | 6 diff (99.4 %id) | ||||
TI_154180950 | .a | 3434 to 4243 | 76 to 877 | 802/804 (99 %) | 22 diff (97.3 %id) | ||||
TI_154181024 | .a | 3074 to 3875 | 69 to 867 | tiling clone, | 799/800 (99 %) | 10 diff (98.8 %id) | |||
TI_154185344 | .a | 574 to 940 | 105 to 470 | 366/1412 (25 %) | 10 diff (99.3 %id) | ||||
TI_157605958 | .b | 1007 to 1590 | 685 to 99 | AAA | Possibly primed on the genome, locally A rich (20/22 A in genome downstream of last aligned base) | 587/951 (61 %) | 16 diff (98.4 %id) | ||
TI_157607860 | .a | 6448 to 6997 | 637 to 88 | AAA | Possibly primed on the genome, locally A rich (20/22 A in genome downstream of last aligned base) | 550/551 (99 %) | 12 diff (97.9 %id) | ||
BQ011567 | placenta | .a | 6538 to 6997 | 478 to 19 | AAA | Possibly primed on the genome, locally A rich (20/22 A in genome downstream of last aligned base) | 460/460 (100 %) | 2 diff (99.6 %id) | |
CF529768 | placenta | .a | 6635 to 6997 | 381 to 19 | AAA | Possibly primed on the genome, locally A rich (20/22 A in genome downstream of last aligned base) | 363/363 (100 %) | 0 diff (100 %id) | |
BM977424 | lung, Primary Lung Cystic Fibrosis EpithelialCells | .a | 6291 to 7002 | 727 to 19 | AAA | Possibly primed on the genome, locally A rich (20/22 A in genome downstream of last aligned base) | 709/710 (99 %) | 7 diff (99.1 %id) | |
BM977424 | lung, Primary Lung Cystic Fibrosis EpithelialCells | .a | 6291 to 7002 | 727 to 19 | AAA | Possibly primed on the genome, locally A rich (20/22 A in genome downstream of last aligned base) | 709/710 (99 %) | 7 diff (99.1 %id) | |
BM668241 | eye, Retina Foveal and Macular | .c | 273 to 682 | 429 to 19 | tiling clone, fully sequenced, AAA | 411/411 (100 %) | 1 diff (99.8 %id) | ||
BM668241 | eye, Retina Foveal and Macular | .c | 273 to 682 | 429 to 19 | tiling clone, fully sequenced, AAA | 411/411 (100 %) | 1 diff (99.8 %id) | ||
BM692924 | eye, Retina Foveal and Macular | .c | 1 to 334 | 1 to 334 | tiling clone, fully sequenced, | 334/334 (100 %) | 1 diff (99.8 %id) | ||
BM692924 | eye, Retina Foveal and Macular | .c | 1 to 334 | 1 to 334 | tiling clone, fully sequenced, | 334/334 (100 %) | 1 diff (99.8 %id) | ||
BM668748 | eye, Retina Foveal and Macular | .a | 6426 to 6997 | 590 to 19 | fully sequenced, AAA | Possibly primed on the genome, locally A rich (20/22 A in genome downstream of last aligned base) | 572/572 (100 %) | 2 diff (99.7 %id) | |
BM668748 | eye, Retina Foveal and Macular | .a | 6426 to 6997 | 590 to 19 | fully sequenced, AAA | Possibly primed on the genome, locally A rich (20/22 A in genome downstream of last aligned base) | 572/572 (100 %) | 2 diff (99.7 %id) | |
BM693470 | eye, Retina Foveal and Macular | .a | 6059 to 6456 | 1 to 398 | fully sequenced, | Possibly primed on the genome, locally A rich (20/22 A in genome downstream of last aligned base) | 398/398 (100 %) | 2 diff (99.5 %id) | |
BM693470 | eye, Retina Foveal and Macular | .a | 6059 to 6456 | 1 to 398 | fully sequenced, | Possibly primed on the genome, locally A rich (20/22 A in genome downstream of last aligned base) | 398/398 (100 %) | 2 diff (99.5 %id) | |
BM688011 | eye, human retina | .a | 6087 to 6681 | 8 to 599 | fully sequenced, | Possibly primed on the genome, locally A rich (20/22 A in genome downstream of last aligned base) | 592/599 (98 %) | 2 diff (99.7 %id) | |
BM688011 | eye, human retina | .a | 6087 to 6681 | 8 to 599 | fully sequenced, | Possibly primed on the genome, locally A rich (20/22 A in genome downstream of last aligned base) | 592/599 (98 %) | 2 diff (99.7 %id) | |
BU726874 | eye, human retina | .a | 6651 to 6998 | 366 to 19 | fully sequenced, AAA | Possibly primed on the genome, locally A rich (20/22 A in genome downstream of last aligned base) | 348/348 (100 %) | 2 diff (99.5 %id) | |
BU726874 | eye, human retina | .a | 6651 to 6998 | 366 to 19 | fully sequenced, AAA | Possibly primed on the genome, locally A rich (20/22 A in genome downstream of last aligned base) | 348/348 (100 %) | 2 diff (99.5 %id) | |
BM692032 | eye, human retina | .a | 6272 to 6831 | 9 to 568 | 560/568 (98 %) | 1 diff (99.9 %id) | |||
BM692032 | eye, human retina | .a | 6272 to 6831 | 9 to 568 | 560/568 (98 %) | 1 diff (99.9 %id) | |||
BM713793 | eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid | .a | 6432 to 7001 | 1 to 570 | 570/576 (98 %) | 4 diff (99.4 %id) | |||
BM713793 | eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid | .a | 6432 to 7001 | 1 to 570 | 570/576 (98 %) | 4 diff (99.4 %id) | |||
BM682281 | eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid | .a | 5112 to 5722 | 625 to 15 | AAA | Possibly primed on the genome, locally A rich (20/22 A in genome downstream of last aligned base) | 611/611 (100 %) | 7 diff (98.9 %id) | |
BM682281 | eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid | .a | 5112 to 5722 | 625 to 15 | AAA | Possibly primed on the genome, locally A rich (20/22 A in genome downstream of last aligned base) | 611/611 (100 %) | 7 diff (98.9 %id) | |
BM723275 | eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid | .a | 4354 to 5101 | 1 to 745 | Possibly primed on the genome, locally A rich (20/22 A in genome downstream of last aligned base) | 745/746 (99 %) | 8 diff (99.0 %id) | ||
BM723275 | eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid | .a | 4354 to 5101 | 1 to 745 | Possibly primed on the genome, locally A rich (20/22 A in genome downstream of last aligned base) | 745/746 (99 %) | 8 diff (99.0 %id) | ||
BQ185983 | eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid | .a | 5040 to 5524 | 1 to 486 | 486/486 (100 %) | 9 diff (98.2 %id) | |||
BQ185983 | eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid | .a | 5040 to 5524 | 1 to 486 | 486/486 (100 %) | 9 diff (98.2 %id) | |||
BQ187309 | eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid | .a | 5036 to 5726 | 1 to 691 | AAA | Possibly primed on the genome, locally A rich (20/22 A in genome downstream of last aligned base) | 691/691 (100 %) | 1 diff (99.9 %id) | |
BQ187309 | eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid | .a | 5036 to 5726 | 1 to 691 | AAA | Possibly primed on the genome, locally A rich (20/22 A in genome downstream of last aligned base) | 691/691 (100 %) | 1 diff (99.9 %id) | |
CA442391 | Fibrosarcoma | .a | 6143 to 6911 | 784 to 16 | AAA | Possibly primed on the genome, locally A rich (20/22 A in genome downstream of last aligned base) | 769/769 (100 %) | 2 diff (99.8 %id) | |
BQ445922 | Knee, Osteoarthritic Cartilage | .a | 6292 to 6997 | 723 to 19 | AAA | Possibly primed on the genome, locally A rich (20/22 A in genome downstream of last aligned base) | 705/705 (100 %) | 3 diff (99.6 %id) | |
BQ445922 | Knee, Osteoarthritic Cartilage | .a | 6292 to 6997 | 723 to 19 | AAA | Possibly primed on the genome, locally A rich (20/22 A in genome downstream of last aligned base) | 705/705 (100 %) | 3 diff (99.6 %id) | |
TI_151707269 | .a | 6212 to 6998 | 877 to 88 | 790/1418 (55 %) | 0 diff (100 %id) | ||||
TI_151734285 | .a | 5035 to 5726 | 773 to 83 | tiling clone, AAA | Possibly primed on the genome, locally A rich (20/22 A in genome downstream of last aligned base) | 691/933 (74 %) | 0 diff (100 %id) | ||
DB268389 | uterus | .a | 4919 to 5473 | 2 to 557 | capped | 556/556 (100 %) | 6 diff (99.0 %id) | ||
W22321 | eye, retina | .a | 2641 to 3086 | 451 to 10 | 442/506 (87 %) | 0 diff (100 %id) | |||
W22321 | eye, retina | .a | 2641 to 3086 | 451 to 10 | 442/506 (87 %) | 0 diff (100 %id) |
? | Gene Summary | Gene on genome | mRNA:.a, .b, .c, .d, .e-u, .f, .g, .h, .i, .j-u | Alternative mRNAs features, proteins, introns, exons, sequences | Expression Tissue | Function, regulation, related genes C |